Equashield to Participate in the American Society of Health-System Pharmacist Midyear Clinical Meeting
PORT WASHINGTON, N.Y., Dec. 5, 2022 /PRNewswire/ -- Equashield, a leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs and exclusive proprietor of the only closed-back Syringe Unit, today announced its participation at the ASHP Midyear Clinical Meeting in Las Vegas, Nevada. Equashield will hold demonstrations of its proprietary closed-back Syringe Unit and its automated compounding system, the Equashield PRO, at the ASHP Midyear Clinical Meeting Exhibition Hall.
- Equashield will hold demonstrations of the only closed-back CSTD and Equashield PRO at ASHP Midyear Meeting in Las Vegas, Nevada.
- Equashield will hold demonstrations of its proprietary closed-back Syringe Unit and its automated compounding system, the Equashield PRO, at the ASHP Midyear Clinical Meeting Exhibition Hall.
- "Equashield is honored to be participating once again in ASHP's Midyear Clinical Meeting," said Marino Kriheli, Product Manager for Equashield.
- ASHP's Midyear Clinical Meeting is the largest event for pharmacists and pharmacy professionals in the world, with over 20,000 people in attendance.